These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 1724027)

  • 1. Antioxidant enzyme activities in hepatic tissue from children with chronic cholestatic liver disease.
    Ismail NA; Okasha SH; Dhawan A; Abdel-Rahman AO; Shaker OG; Sadik NA
    Saudi J Gastroenterol; 2010; 16(2):90-4. PubMed ID: 20339177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enzyme system for dismutation of active forms of oxygen in the liver during chronic impairment of the hepatobiliary system].
    Loginov AS; Matiushin BN; Tkachev VD
    Vopr Med Khim; 1991; 37(1):31-3. PubMed ID: 1858337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antioxidant liver enzymes in chronic liver disease].
    Matiushin BN; Loginov AS; Tkachev VD
    Patol Fiziol Eksp Ter; 1992; (2):41-2. PubMed ID: 1408393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superoxide dismutase and glutathione in the gastric mucosa of patients with chronic liver disease.
    Kikkawa S; Kadohara M; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):289-309. PubMed ID: 1335597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural localization of Cu, Zn-SOD in hepatocytes of patients with various liver diseases.
    Saito T; Shinzawa H; Togashi H; Wakabayashi H; Ukai K; Takahashi T; Ishikawa M; Dobashi M; Imai Y
    Histol Histopathol; 1989 Jan; 4(1):1-6. PubMed ID: 2485185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical significance of the enzymatic system utilizing active forms of oxygen in chronic liver diseases].
    Loginov AS; Matiushin BN
    Ter Arkh; 1994; 66(4):65-8. PubMed ID: 8016735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Active forms of oxygen: cytotoxic effects and methodological approaches to laboratory control of liver lesions (literature review)].
    Matiushin BN; Loginov AS
    Klin Lab Diagn; 1996; (4):51-3. PubMed ID: 8963562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of fibrosis in chronic liver diseases: time to tally the score.
    Pinzani M; Romanelli RG; Magli S
    J Hepatol; 2001 May; 34(5):764-7. PubMed ID: 11434626
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of the superoxide dismutase activity in puncture biopsy specimens of the liver in chronic liver diseases].
    Matiushin BN; Loginov AS; Tkachev VD
    Lab Delo; 1991; (7):16-9. PubMed ID: 1724027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading and staging systems for inflammation and fibrosis in chronic liver diseases.
    Goodman ZD
    J Hepatol; 2007 Oct; 47(4):598-607. PubMed ID: 17692984
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.